Clinical Trial

Development and Validation of a cCTA and Biomarker Based Risk Model for Coronary Revascularization in Elderly Patients With Coronary Artery Disease

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is a prospective multi-center observational cohort involving elderly patients (≥70 years old) with multi-vessel coronary disease identified by coronary computed tomography angiography (cCTA) and scheduled for invasive coronary angiography. Data collection about cCTA, frailty and biomarkers and two-year follow-up will be conducted to develop and validate a risk model of coronary revascularization.
Trial Details
NCT Number NCT07311954
Lead Sponsor China National Center for Cardiovascular Diseases
Collaborators: Central China Fuwai Hospital of Zhengzhou University, Chinese Academy of Medical Sciences, Fuwai Hospital
Conditions Coronary Artery Disease, Elderly (Aged >70)
Enrollment 800 participants
Start Date 2026-01-01
Primary Completion 2029-01-01 (estimated)
Study Completion 2029-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-31